Leading the Charge

Our groundbreaking science is the foundation of our innovative clinical program

Read More

 
 

First-in-Class Cancer Therapeutic

Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Clinical Program

We are focused on the clinical development of imetelstat in hematologic myeloid malignancies.

Read More

Leading the Charge

Our groundbreaking science is the foundation of our innovative clinical program

Read More

Close
Form content here please :)